Tokyo, Jan. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060038) titled 'Study on the association between metabolic dysfunction-associated steatotic liver disease (MASLD) and serum concentrations of fatty acids' on Jan. 1.
Study Type:
Observational
Primary Sponsor:
Institute - University of Tsukuba
Condition:
Condition - metabolic dysfunction-associated steatotic liver disease (MASLD)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To develop indicators which correlate with liver fat accumulation in patients with MASLD, using serum concentrations of fatty acids
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Female
Key inclusion criteria - MASLD was diagnosed as patients with hepatic steatosis identified by imaging, and any of 1) to 3)
1) Overweight or Obesity
2) type 2 diabetes
3) at least, two metabolic diseases; hypertention, visceral fat accumulation, glucose intolerance, and dyslipidemia
Key exclusion criteria - while undergoing cancer therapy
CT scan within 1 year
Target Size - 80
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 07 Month 10 Day
Date of IRB - 2025 Year 07 Month 22 Day
Anticipated trial start date - 2025 Year 09 Month 01 Day
Last follow-up date - 2030 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068621
Disclaimer: Curated by HT Syndication.
